drugset / Trial / NCT00041275

Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

NCT00041275

RandomizedDouble-blindTreatment

Summary

RATIONALE: Estrogen can stimulate the growth of cancer cells. Hormone therapy using megestrol may fight liver cancer by blocking the uptake of estrogen. It is not yet known if megestrol is an effective treatment for liver cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of megestrol in treating patients who have liver cancer that cannot be removed by surgery.

Timeline

Start
2002-05
Primary completion
2007-06
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Megestrol Acetate Other / unclassified 320 mg Oral

Indications